Nina Keldsen

1.4k total citations
31 papers, 602 citations indexed

About

Nina Keldsen is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Reproductive Medicine. According to data from OpenAlex, Nina Keldsen has authored 31 papers receiving a total of 602 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 9 papers in Pulmonary and Respiratory Medicine and 7 papers in Reproductive Medicine. Recurrent topics in Nina Keldsen's work include Colorectal Cancer Treatments and Studies (11 papers), Ovarian cancer diagnosis and treatment (7 papers) and Cancer Treatment and Pharmacology (6 papers). Nina Keldsen is often cited by papers focused on Colorectal Cancer Treatments and Studies (11 papers), Ovarian cancer diagnosis and treatment (7 papers) and Cancer Treatment and Pharmacology (6 papers). Nina Keldsen collaborates with scholars based in Denmark, Sweden and Norway. Nina Keldsen's co-authors include Anders Jakobsen, Per Pfeiffer, Benny Vittrup Jensen, Svend Erik Nielsen, Søren M. Bentzen, Wojciech Michalski, K Thorling, K. Bertelsen, Hanne Havsteen and Åke Berglund and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Annals of Oncology.

In The Last Decade

Nina Keldsen

30 papers receiving 593 citations

Peers

Countries citing papers authored by Nina Keldsen

Since Specialization

Citations

This map shows the geographic impact of Nina Keldsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nina Keldsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nina Keldsen more than expected).

Fields of papers citing papers by Nina Keldsen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nina Keldsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nina Keldsen. The network helps show where Nina Keldsen may publish in the future.

Co-authorship network of co-authors of Nina Keldsen

This figure shows the co-authorship network connecting the top 25 collaborators of Nina Keldsen. A scholar is included among the top collaborators of Nina Keldsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nina Keldsen. Nina Keldsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Impairment of Lung Function During Adjuvant Oxaliplatin Treatment in Patients with Colorectal Cancer: A Prospective Trial 2016 ·Current Drug Safety ·Nina Keldsen, (unknown), June Anita Ejlersen	1
2	Tissue MicroRNAs as Predictors of Outcome in Patients with Metastatic Colorectal Cancer Treated with First Line Capecitabine and Oxaliplatin with or without Bevacizumab 2014 ·PLoS ONE ·Mogens K. Boisen, Christian Dehlendorff, Dorte Linnemann, Boye Schnack Nielsen, Jim S. Larsen, Kell Østerlind, Svend Erik Nielsen, Line Schmidt Tarpgaard, Camilla Qvortrup, Per Pfeiffer, Niels Henrik Holländer, Nina Keldsen, Torben Frøstrup Hansen, Brita B. Jensen, Estrid Høgdall, Benny Vittrup Jensen, Julia S. Johansen	40
3	Primary tumor location and bevacizumab effectiveness in patients with metastatic colorectal cancer 2013 ·Annals of Oncology ·Mogens K. Boisen, Julia S. Johansen, Christian Dehlendorff, Jim S. Larsen, Kell Østerlind, Josie Hansen, Svend Erik Nielsen, Per Pfeiffer, Line Schmidt Tarpgaard, Niels Henrik Holländer, Nina Keldsen, Torben Frøstrup Hansen, Brita B. Jensen, Benny Vittrup Jensen	76
4	A randomized phase III trial on maintenance treatment with bevacizumab alone or in combination with erlotinib after chemotherapy and bevacizumab in metastatic colorectal cancer: the Nordic ACT Trial 2013 ·Annals of Oncology ·Anna Johnsson, Helga Hagman, Jan‐Erik Frödin, Åke Berglund, Nina Keldsen, Eva Fernebro, J. Sundberg, (unknown), K.-L.G. Spindler, (unknown), Anders Jakobsen	59
5	Panitumumab and Pegylated Liposomal Doxorubicin in Platinum-Resistant Epithelial Ovarian Cancer With KRAS Wild-Type 2012 ·International Journal of Gynecological Cancer ·Karina Dahl Steffensen, Marianne Waldstrøm, (unknown), Bente Lund, Kjell Bergfeldt, (unknown), Nina Keldsen, Christian Marth, Ignace Vergote, Anders Jakobsen	16
6	Impact ofABCB1Variants on Neutrophil Depression: A Pharmacogenomic Study of Paclitaxel in 92 Women with Ovarian Cancer 2011 ·Basic & Clinical Pharmacology & Toxicology ·Troels K. Bergmann, Charlotte Brasch‐Andersen, Henrik Gréen, Mansoor Raza Mirza, (unknown), (unknown), Nina Keldsen, Per Damkier, Curt Peterson, Werner Vach, Kim Brøsen	38
7	Plasma TIMP-1 levels and treatment outcome in patients treated with XELOX for metastatic colorectal cancer 2010 ·Annals of Oncology ·(unknown), Camilla Qvortrup, Ib Jarle Christensen, Bengt Glimelius, Åke Berglund, Benny Vittrup Jensen, Svend Erik Nielsen, Nina Keldsen, Hans Jørgen Nielsen, Nils Brünner, Per Pfeiffer	19
8	Impact of CYP2C83 on paclitaxel clearance: a population pharmacokinetic and pharmacogenomic study in 93 patients with ovarian cancer 2010 ·The Pharmacogenomics Journal* ·Troels K. Bergmann, Charlotte Brasch‐Andersen, Henrik Gréen, Mansoor Raza Mirza, Rasmus S. Pedersen, Flemming Nielsen, (unknown), (unknown), Nina Keldsen, Per Damkier, Lena E. Friberg, C. Peterson, Werner Vach, Mats O. Karlsson, Kim Brøsen	78
9	A phase II study of combination chemotherapy in early relapsed epithelial ovarian cancer using gemcitabine and pegylated liposomal doxorubicin 2010 ·Gynecologic Oncology ·Mansoor Raza Mirza, Bente Lund, Jacob Christian Lindegaard, Nina Keldsen, Anders Mellemgaard, René dePont Christensen, K. Bertelsen	8
10	A randomized study comparing short-time infusion of oxaliplatin in combination with capecitabine XELOX30 and chronomodulated XELOX30 as first-line therapy in patients with advanced colorectal cancer 2009 ·Annals of Oncology ·Camilla Qvortrup, Benny Vittrup Jensen, Tone Fokstuen, Svend Erik Nielsen, Nina Keldsen, Bengt Glimelius, Beth Bjerregaard, Johannes Mejer, Finn Ole Larsen, Per Pfeiffer	34
11	A randomized phase III multicenter trial comparing irinotecan in combination with the Nordic bolus 5-FU and folinic acid schedule or the bolus/infused de Gramont schedule (Lv5FU2) in patients with metastatic colorectal cancer 2008 ·Annals of Oncology ·Bengt Glimelius, Halfdan Sørbye, Lise Balteskard, Per Byström, Per Pfeiffer, Kjell M. Tveit, Reino Heikkilä, Nina Keldsen, M. Albertsson, Hans Starkhammar, Hans Garmo, Åke Berglund	36
12	Half body irradiation of patients with multiple bone metastases: A phase II trial 2008 ·Acta Oncologica ·(unknown), Mette Yilmaz, Morten Høyer, Nina Keldsen, Ole S. Nielsen, Marianne Ewertz	18
13	Altretamine (hexamethylmelamine) in the treatment of platinum-resistant ovarian cancer: a phase II study 2003 ·Gynecologic Oncology ·Nina Keldsen, Hanne Havsteen, Ignace Vergote, K. Bertelsen, Anders Jakobsen	42
14	Oral Treosulfan as Second-Line Treatment in Platinum-Resistant Ovarian Cancer: A Phase II Study 1998 ·Gynecologic Oncology ·Nina Keldsen, Ebbe Lindegaard Madsen, Hanne Havsteen, Claus Kamby, (unknown), (unknown)	11
15	Risk Factors for Central Nervous System Involvement in Non-Hodgkins-Lymphoma a multivariate analysis 1996 ·Acta Oncologica ·Nina Keldsen, Wojciech Michalski, Søren M. Bentzen, (unknown), K Thorling	53
16	Multiple myeloma treated with mitoxantrone in combination with vincristine and prednisolone (NOP regimen) versus melphalan and prednisolone: a phase III study 1993 ·European Journal Of Haematology ·Nina Keldsen, Ole Weis Bjerrum, Inger Marie S. Dahl, Aage Drivsholm, Jørgen Ellegaard, Ole Gadeberg, Peter Gimsing, (unknown), Mogens Hansen, Erik Hippe, Jon Lamvik, Bernt Ly, (unknown), Ingebrigt Talstad, K Thorling, (unknown), (unknown)	3
17	Refractory myelomatosis treated with mitoxantrone in combination with vincristine and prednisone (NOP‐regimen): a phase II study 1991 ·British Journal of Haematology ·Peter Gimsing, Ole Weis Bjerrum, (unknown), (unknown), Stein A. Evensen, (unknown), Michael Hedenus, Erik Hippe, Nina Keldsen, I. P. Palva, (unknown), Ingebrigt Talstad, (unknown), (unknown)	12
18	Haematological effects from Radioiodine Treatment of Thyroid Carcinoma 1990 ·Acta Oncologica ·Nina Keldsen, (unknown), Harald S. Hansen	15
19	Cisplatin as Second Line Chemotherapy in Advanced or Recurrent Squamous Cell Carcinoma of Head and Neck Region 1987 ·Acta Oncologica ·Nina Keldsen	2
20	Translocations and deletions with breakpoint on 21q are nonrandomly associated with treatment-related acute nonlymphocytic leukemia and preleukemia 1987 ·Cancer Genetics and Cytogenetics ·Nina Keldsen, Preben Philip, J Pedersen-Bjergaard	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact